Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Allison C. Brown is active.

Publication


Featured researches published by Allison C. Brown.


Cornea | 2014

Clinical characteristics of Acanthamoeba keratitis infections in 28 states, 2008 to 2011.

Jonathan Ross; Sharon L. Roy; William D. Mathers; David C. Ritterband; Jonathan S. Yoder; Tracy Ayers; Rupa D. Shah; Monika E. Samper; Carolyn Shih; Ann Schmitz; Allison C. Brown

Purpose: The aim was to describe a geographically and clinically diverse sample of cases of Acanthamoeba keratitis (AK) and establish the risk factors for poor outcomes among patients with this disease. Methods: We conducted a retrospective, population-based case series of 116 patients with AK identified through a national surveillance network. Data were collected via a medical record review by diagnosing ophthalmologists and by phone interviews with patients. Exact logistic regression modeling was used to determine risk factors for poor visual outcomes. Results: Among patients with data available on contact lens use, it was found that 93.3% wore contact lenses. The median time from symptom onset to care seeking was 2 days, whereas the median time from symptom onset to diagnosis was 27 days. Keratoplasty was performed in 27 of 81 patients with available outcome data and was more likely in patients >40 years old [odds ratio (OR) 5.25, 95% confidence interval (CI) 1.49–21.92]. When adjusted for age, the risk factors for keratoplasty included the presence of a ring infiltrate (OR 40.00, 95% CI 3.58–447.0) or any sign of stromal invasion (OR 10.48, 95% CI 2.56–55.09). One-third of patients with available data on best-corrected visual acuity had a best-corrected visual acuity <20/200, with the presence of a ring infiltrate as the only significant predictor of this outcome when adjusted for age (aOR 3.45, 95% CI 1.01–12.31). Conclusions: AK remains challenging to diagnose. Consequently, patients with advanced disease are more likely to have poor outcomes, particularly if they are older. The increasing awareness of AK among general eye care providers may shorten referral times and potentially improve outcomes.


Antimicrobial Agents and Chemotherapy | 2015

Identification and Characterization of Multidrug-Resistant Salmonella enterica Serotype Albert Isolates in the United States

Jason P. Folster; Davina Campbell; Julian Grass; Allison C. Brown; Amelia Bicknese; Beth Tolar; Lavin A. Joseph; Jodie R. Plumblee; Carrie Walker; Paula J. Fedorka-Cray; Jean M. Whichard

ABSTRACT Salmonella enterica is one of the most common causes of bacterial foodborne illness in the United States. Although most Salmonella infections are self-limiting, antimicrobial treatment of invasive salmonellosis is critical. The primary antimicrobial treatment options include fluoroquinolones or extended-spectrum cephalosporins, and resistance to these antimicrobial drugs may complicate treatment. At present, S. enterica is composed of more than 2,600 unique serotypes, which vary greatly in geographic prevalence, ecological niche, and the ability to cause human disease, and it is important to understand and mitigate the source of human infection, particularly when antimicrobial resistance is found. In this study, we identified and characterized 19 S. enterica serotype Albert isolates collected from food animals, retail meat, and humans in the United States during 2005 to 2013. All five isolates from nonhuman sources were obtained from turkeys or ground turkey, and epidemiologic data suggest poultry consumption or live-poultry exposure as the probable source of infection. S. enterica serotype Albert also appears to be geographically localized to the midwestern United States. All 19 isolates displayed multidrug resistance, including decreased susceptibility to fluoroquinolones and resistance to extended-spectrum cephalosporins. Turkeys are a likely source of multidrug-resistant S. enterica serotype Albert, and circulation of resistance plasmids, as opposed to the expansion of a single resistant strain, is playing a role. More work is needed to understand why these resistance plasmids spread and how their presence and the serotype they reside in contribute to human disease.


Antimicrobial Agents and Chemotherapy | 2017

Comparative Analysis of Extended-Spectrum-β-Lactamase CTX-M-65-Producing Salmonella enterica Serovar Infantis Isolates from Humans, Food Animals, and Retail Chickens in the United States

Heather Tate; Jason P. Folster; Chih-Hao Hsu; Jessica L. Chen; Maria Hoffmann; Cong Li; Cesar A. Morales; Gregory H. Tyson; Sampa Mukherjee; Allison C. Brown; Alice L. Green; Wanda Wilson; Uday Dessai; Jason Abbott; Lavin A. Joseph; Jovita Haro; Sherry Ayers; Patrick F. McDermott; Shaohua Zhao

ABSTRACT We sequenced the genomes of 10 Salmonella enterica serovar Infantis isolates containing blaCTX-M-65 obtained from chicken, cattle, and human sources collected between 2012 and 2015 in the United States through routine National Antimicrobial Resistance Monitoring System (NARMS) surveillance and product sampling programs. We also completely assembled the plasmids from four of the isolates. All isolates had a D87Y mutation in the gyrA gene and harbored between 7 and 10 resistance genes [aph(4)-Ia, aac(3)-IVa, aph(3′)-Ic, blaCTX-M-65, fosA3, floR, dfrA14, sul1, tetA, aadA1] located in two distinct sites of a megaplasmid (∼316 to 323 kb) similar to that described in a blaCTX-M-65-positive S. Infantis isolate from a patient in Italy. High-quality single nucleotide polymorphism (hqSNP) analysis revealed that all U.S. isolates were closely related, separated by only 1 to 38 pairwise high-quality SNPs, indicating a high likelihood that strains from humans, chickens, and cattle recently evolved from a common ancestor. The U.S. isolates were genetically similar to the blaCTX-M-65-positive S. Infantis isolate from Italy, with a separation of 34 to 47 SNPs. This is the first report of the blaCTX-M-65 gene and the pESI (plasmid for emerging S. Infantis)-like megaplasmid from S. Infantis in the United States, and it illustrates the importance of applying a global One Health human and animal perspective to combat antimicrobial resistance.


Emerging Infectious Diseases | 2017

Epidemiology of Salmonellaenterica Serotype Dublin Infections among Humans, United States, 1968–2013

R. Reid Harvey; Cindy R. Friedman; Stacy M. Crim; Michael Judd; Kelly A. Barrett; Beth Tolar; Jason P. Folster; Patricia M. Griffin; Allison C. Brown

Infection incidence and antimicrobial drug resistance are increasing.


American Journal of Tropical Medicine and Hygiene | 2016

A Cluster Randomized Controlled Evaluation of the Health Impact of a Novel Antimicrobial Hand Towel on the Health of Children Under 2 Years Old in Rural Communities in Nyanza Province, Kenya

Rachel B. Slayton; Jennifer L. Murphy; Jamae Morris; Sitnah Hamidah Faith; Jared Oremo; Aloyce Odhiambo; Tracy Ayers; Shawna J. Feinman; Allison C. Brown; Robert Quick

To assess the health impact of reusable, antimicrobial hand towels, we conducted a cluster randomized, yearlong field trial. At baseline, we surveyed mothers, and gave four towels plus hygiene education to intervention households and education alone to controls. At biweekly home visits, we asked about infections in children < 2 years old and tested post-handwashing hand rinse samples of 20% of mothers for Escherichia coli. At studys conclusion, we tested 50% of towels for E. coli. Baseline characteristics between 188 intervention and 181 control households were similar. Intervention and control children had similar rates of diarrhea (1.47 versus 1.48, P = 0.99), respiratory infections (1.38 versus 1.48, P = 0.92), skin infections (1.76 versus 1.79, P = 0.81), and subjective fever (2.62 versus 3.40, P = 0.04) per 100 person-visits. Post-handwashing hand contamination was similar; 67% of towels exhibited E. coli contamination. Antimicrobial hand towels became contaminated over time, did not improve hand hygiene, or prevent diarrhea, respiratory infections, or skin infections.


Eye & Contact Lens-science and Clinical Practice | 2017

Risk Factors for Acanthamoeba Keratitis—A Multistate Case–Control Study, 2008–2011

Allison C. Brown; Jonathan Ross; Daniel B. Jones; Sarah A. Collier; Tracy Ayers; Robert M. Hoekstra; Bryon Backensen; Sharon L. Roy; Michael J. Beach; Jonathan S. Yoder

Objective: To identify modifiable risk factors contributing to Acanthamoeba keratitis (AK) infection. Methods: A case–control investigation was conducted. Case patients were soft contact lens wearers with laboratory-confirmed AK. Control were soft contact lens wearers ≥12 years of age, with no history of AK. Case patients were recruited from 14 ophthalmology referral centers and a clinical laboratory. Control were matched on state of residence and type of primary eye care provider (ophthalmologist or optometrist). Participants were interviewed using a standardized questionnaire. Univariable and multivariable conditional logistic regression analyses were conducted. Matched odds ratios (mORs) were calculated. Results: Participants included 88 case patients and 151 matched control. Case patients were more likely to be aged <25 years (unadjusted mOR 2.7, 95% confidence interval 1.3–5.5) or aged >53 years (mOR 2.5, 1.1–5.7), and more likely to be men (mOR 2.6, 1.4–4.8). Unadjusted analyses identified multiple risk factors: rinsing (mOR 6.3, 1.3–29.9) and storing lenses in tap water (mOR 3.9, 1.2–12.3), topping off solution in the lens case (mOR 4.0, 2.0–8.0), having worn lenses ⩽5 years (mOR 2.4, 1.3–4.4), rinsing the case with tap water before storing lenses (mOR 2.1, 1.1–4.1), and using hydrogen peroxide (mOR 3.6, 1.1–11.7) versus multipurpose solution. Significant risk factors in multivariable modeling included age >53 years, male sex, topping off, and using saline solution. Conclusions: Numerous modifiable risk factors for AK were identified, mostly involving hygiene practices. To reduce the risk of AK, lens wearers should observe recommended lens care practices.


Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) | 2016

Immediate Closures and Violations Identified During Routine Inspections of Public Aquatic Facilities - Network for Aquatic Facility Inspection Surveillance, Five States, 2013.

Michele C. Hlavsa; Taryn R. Gerth; Sarah A. Collier; Elizabeth L. Dunbar; Gouthami Rao; Gregory Epperson; Becky Bramlett; David F. Ludwig; Diana Gomez; Monty M. Stansbury; Freeman Miller; Jeffrey Warren; Jim Nichol; Harry Bowman; Bao-An Huynh; Kara M. Loewe; Bob Vincent; Amanda L. Tarrier; Timothy Shay; Robert Wright; Allison C. Brown; Jasen Kunz; Kathleen E. Fullerton; James R. Cope; Michael J. Beach

PROBLEM/CONDITION Aquatic facility-associated illness and injury in the United States include disease outbreaks of infectious or chemical etiology, drowning, and pool chemical-associated health events (e.g., respiratory distress or burns). These conditions affect persons of all ages, particularly young children, and can lead to disability or even death. A total of 650 aquatic facility-associated outbreaks have been reported to CDC for 1978-2012. During 1999-2010, drownings resulted in approximately 4,000 deaths each year in the United States. Drowning is the leading cause of injury deaths in children aged 1-4 years, and approximately half of fatal drownings in this age group occur in swimming pools. During 2003-2012, pool chemical-associated health events resulted in an estimated 3,000-5,000 visits to U.S. emergency departments each year, and approximately half of the patients were aged <18 years. In August 2014, CDC released the Model Aquatic Health Code (MAHC), national guidance that can be adopted voluntarily by state and local jurisdictions to minimize the risk for illness and injury at public aquatic facilities. REPORTING PERIOD COVERED 2013. DESCRIPTION OF SYSTEM The Network for Aquatic Facility Inspection Surveillance (NAFIS) was established by CDC in 2013. NAFIS receives aquatic facility inspection data collected by environmental health practitioners when assessing the operation and maintenance of public aquatic facilities. This report presents inspection data that were reported by 16 public health agencies in five states (Arizona, California, Florida, New York, and Texas) and focuses on 15 MAHC elements deemed critical to minimizing the risk for illness and injury associated with aquatic facilities (e.g., disinfection to prevent transmission of infectious pathogens, safety equipment to rescue distressed bathers, and pool chemical safety). Although these data (the first and most recent that are available) are not nationally representative, 15.7% of the estimated 309,000 U.S. public aquatic venues are located in the 16 reporting jurisdictions. RESULTS During 2013, environmental health practitioners in the 16 reporting NAFIS jurisdictions conducted 84,187 routine inspections of 48,632 public aquatic venues. Of the 84,187 routine inspection records for individual aquatic venues, 78.5% (66,098) included data on immediate closure; 12.3% (8,118) of routine inspections resulted in immediate closure because of at least one identified violation that represented a serious threat to public health. Disinfectant concentration violations were identified during 11.9% (7,662/64,580) of routine inspections, representing risk for aquatic facility-associated outbreaks of infectious etiology. Safety equipment violations were identified during 12.7% (7,845/61,648) of routine inspections, representing risk for drowning. Pool chemical safety violations were identified during 4.6% (471/10,264) of routine inspections, representing risk for pool chemical-associated health events. INTERPRETATION Routine inspections frequently resulted in immediate closure and identified violations of inspection items corresponding to 15 MAHC elements critical to protecting public health, highlighting the need to improve operation and maintenance of U.S. public aquatic facilities. These findings also underscore the public health function that code enforcement, conducted by environmental health practitioners, has in preventing illness and injury at public aquatic facilities. PUBLIC HEALTH ACTION Findings from the routine analyses of aquatic facility inspection data can inform program planning, implementation, and evaluation. At the state and local level, these inspection data can be used to identify aquatic facilities and venues in need of more frequent inspections and to select topics to cover in training for aquatic facility operators. At the national level, these data can be used to evaluate whether the adoption of MAHC elements minimizes the risk for aquatic facility-associated illness and injury. These findings also can be used to prioritize revisions or updates to the MAHC. To optimize the collection and analysis of aquatic facility inspection data and thus application of findings, environmental health practitioners and epidemiologists need to collaborate extensively to identify public aquatic facility code elements deemed critical to protecting public health and determine the best way to assess and document compliance during inspections.


Morbidity and Mortality Weekly Report | 2018

Vital Signs : Containment of novel multidrug-resistant organisms and resistance mechanisms — United States, 2006–2017

Kate Woodworth; Maroya Spaldin Walters; Lindsey M. Weiner; Jonathan R. Edwards; Allison C. Brown; Jennifer Y. Huang; Sarah Malik; Rachel B. Slayton; Prabasaj Paul; Catherine Capers; Marion Kainer; Nancy Wilde; Alicia Shugart; Garrett Mahon; Jean B. Patel; L. Clifford McDonald; Arjun Srinivasan; Michael Craig; Denise M. Cardo

Background Approaches to controlling emerging antibiotic resistance in health care settings have evolved over time. When resistance to broad-spectrum antimicrobials mediated by extended-spectrum β-lactamases (ESBLs) arose in the 1980s, targeted interventions to slow spread were not widely promoted. However, when Enterobacteriaceae with carbapenemases that confer resistance to carbapenem antibiotics emerged, directed control efforts were recommended. These distinct approaches could have resulted in differences in spread of these two pathogens. CDC evaluated these possible changes along with initial findings of an enhanced antibiotic resistance detection and control strategy that builds on interventions developed to control carbapenem resistance. Methods Infection data from the National Healthcare Safety Network from 2006–2015 were analyzed to calculate changes in the annual proportion of selected pathogens that were nonsusceptible to extended-spectrum cephalosporins (ESBL phenotype) or resistant to carbapenems (carbapenem-resistant Enterobacteriaceae [CRE]). Testing results for CRE and carbapenem-resistant Pseudomonas aeruginosa (CRPA) are also reported. Results The percentage of ESBL phenotype Enterobacteriaceae decreased by 2% per year (risk ratio [RR] = 0.98, p<0.001); by comparison, the CRE percentage decreased by 15% per year (RR = 0.85, p<0.01). From January to September 2017, carbapenemase testing was performed for 4,442 CRE and 1,334 CRPA isolates; 32% and 1.9%, respectively, were carbapenemase producers. In response, 1,489 screening tests were performed to identify asymptomatic carriers; 171 (11%) were positive. Conclusions The proportion of Enterobacteriaceae infections that were CRE remained lower and decreased more over time than the proportion that were ESBL phenotype. This difference might be explained by the more directed control efforts implemented to slow transmission of CRE than those applied for ESBL-producing strains. Increased detection and aggressive early response to emerging antibiotic resistance threats have the potential to slow further spread.


Journal of Clinical Microbiology | 2017

FDA-CDC Antimicrobial Resistance Isolate Bank: A Publicly-Available Resource to Support Research, Development and Regulatory Requirements

Joseph D. Lutgring; María-José Machado; Faiza H. Benahmed; Patricia Conville; Ribhi Shawar; Jean B. Patel; Allison C. Brown

ABSTRACT The FDA-CDC Antimicrobial Resistance Isolate Bank was created in July 2015 as a publicly available resource to combat antimicrobial resistance. It is a curated repository of bacterial isolates with an assortment of clinically important resistance mechanisms that have been phenotypically and genotypically characterized. In the first 2 years of operation, the bank offered 14 panels comprising 496 unique isolates and had filled 486 orders from 394 institutions throughout the United States. New panels are being added.


Ophthalmology | 2016

Acanthamoeba Keratitis among Rigid Gas Permeable Contact Lens Wearers in the United States, 2005 through 2011

Jennifer R. Cope; Sarah A. Collier; Oliver D. Schein; Allison C. Brown; Jennifer R. Verani; Rachel Gallen; Michael J. Beach; Jonathan S. Yoder

Collaboration


Dive into the Allison C. Brown's collaboration.

Top Co-Authors

Avatar

Jonathan S. Yoder

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Michael J. Beach

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Sarah A. Collier

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jason P. Folster

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Tracy Ayers

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Beth Tolar

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jean B. Patel

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jennifer R. Cope

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jennifer R. Verani

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Jonathan Ross

Montefiore Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge